Uncovering Clinical Trial Engagement Among Individuals With Borderline Personality Disorder
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Borderline Personality Disorder
- Sponsor
- Power Life Sciences Inc.
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Rate of patients who remain in borderline personality disorder clinical research to trial completion
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Taking part in medical study usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This study will admit a wide range of data on the clinical research experience of borderline personality disorder patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future borderline personality disorder patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Aged ≥ 18 years old
- •Clinical diagnosis of Borderline Personality Disorder
- •Able to comprehend the investigational nature of the protocol and provide informed consent
Exclusion Criteria
- •No diagnosis of Borderline Personality Disorder confirmed
- •Inability to perform regular electronic reporting
- •Patient does not understand, sign, and return consent form
Outcomes
Primary Outcomes
Rate of patients who remain in borderline personality disorder clinical research to trial completion
Time Frame: 12 months
Number of patients who decide to enroll in a borderline personality disorder clinical research
Time Frame: 3 months